abnormal placenta labyrinth morphology_Hsd17b2<tm1Mpo>/Hsd17b2<tm1Mpo>

http://metadb.riken.jp/0001716I129S7SvEvBrdHsd17b2tm1MpoHsd17b2tm1MpoHsd17b2tm1Mpo

abnormal placenta labyrinth morphology_Hsd17b2<tm1Mpo>/Hsd17b2<tm1Mpo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• hydroxysteroid (17-beta) dehydrogenase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1096386

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Hsd17b2<tm1Mpo>/Hsd17b2<tm1Mpo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Hsd17b2<tm1Mpo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal placenta labyrinth morphology
  http://purl.obolibrary.org/obo/MP_0001716

文献

http://purl.org/net/cito/citesAsAuthority

• Pia. Rantakari, et.al., Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene., Molecular endocrinology (Baltimore, Md.), 2008, 22
  http://rdf.ncbi.nlm.nih.gov/pubmed/18048640